Version 2 software

Important: Version 2 Users

If you own V2 and need to reinstall it on a new machine,
send us a note at [email protected] and we'll send a link to V2.

Join our E-mail Newsletter

Valid e-mail is required.
Learn about new meta-analysis workshops & software features, and receive special tools to help with your research.

Comprehensive Meta-Analysis

software image

Comprehensive Meta-Analysis (CMA) is a powerful computer program for meta-analysis. The program combines ease of use with a wide array of computational options and sophisticated graphics.


"I have used Comprehensive Meta‐Analysis since I was a student and it has been the basis for dozens of meta‐analysis publications since then. The strengths of the software include its intuitive approaches to statistical issues, ease of use, and clear presentation of the data. Journals appreciate that important changes in figures can be made rapidly and clearly. This has also been an excellent tool for teaching students and colleagues about conducting meta‐analysis ‐ students enjoy the clarity of presentation and ease of use. With all the ease of use, it is important to note that the software allows a variety of statistical approaches that may be difficult to implement in other software, from choices of metaregression effects to presentations of heterogeneity. For my group, this software is indispensable."

Edward Mills PhD, MSc - LLM Canada, Research Chair, Faculty of Health Sciences, University of Ottawa


"The meta‐analysis program is easy to use and provides me with information that would be hard to get by any other means. I analyze a lot of data and, believe it or not, use the meta‐analysis program every day. I am not a statistician, but the results I produce have routinely been verified by statistical consultants costing large amounts for their confirmatory analyses. Without verification, I have used the results to make important decisions regarding a potential billion dollar a year product. At night I wonder, “What would I have done without this great program.”"

Louis Fabre MD, PhD - Chairman, Fabre‐Kramer Pharmaceuticals Inc.